Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenström's Macroglobulinemia”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Ended earlyNCT01796470
What this trial is testing

Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+1 more
Gilead Sciences 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03620903
What this trial is testing

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Christian Buske 53
Testing effectiveness (Phase 2)Study completedNCT00398710
What this trial is testing

A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
AEterna Zentaris 37
Not applicableStudy completedNCT06084650
What this trial is testing

Optical Coherence Tomography (OCT) and OCT Angiography(OCTA) Deep Learning in Waldenström's Macroglobulinemia Patients

Who this might be right for
Waldenstrom Macroglobulinemia
Federico II University 20
Testing effectiveness (Phase 2)Study completedNCT02363439
What this trial is testing

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Who this might be right for
Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT03269552
What this trial is testing

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma

Who this might be right for
Marginal Zone LymphomaRecurrent Marginal Zone LymphomaRecurrent Waldenstrom Macroglobulinemia+3 more
University of Washington 4
Testing effectiveness (Phase 2)Looking for participantsNCT03697356
What this trial is testing

R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
Kosin University Gospel Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00777738
What this trial is testing

Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Assistance Publique - Hôpitaux de Paris 34
Testing effectiveness (Phase 2)Ended earlyNCT03037645
What this trial is testing

Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoplasmacytoid Lymphoma+5 more
Sunesis Pharmaceuticals 39
Large-scale testing (Phase 3)Study completedNCT00608374
What this trial is testing

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

Who this might be right for
Lymphoma
Taunton and Somerset Hospital 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04263480
What this trial is testing

Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Christian Buske 99
Large-scale testing (Phase 3)Study completedNCT02165397
What this trial is testing

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
Pharmacyclics LLC. 181
Large-scale testing (Phase 3)Looking for participantsNCT04061512
What this trial is testing

Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

Who this might be right for
Waldenstrom Macroglobulinemia
University College, London 148
Not applicableStudy completedNCT03521596
What this trial is testing

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

Who this might be right for
Waldenstrom Macroglobulinemia
Fondazione Italiana Linfomi - ETS 300
Testing effectiveness (Phase 2)Temporarily pausedNCT04840602
What this trial is testing

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Who this might be right for
Lymphoplasmacytic LymphomaWaldenstrom Macroglobulinemia
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)UnknownNCT03261349
What this trial is testing

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Who this might be right for
Indolent Lymphoma
National Taiwan University Hospital 21
Early research (Phase 1)WithdrawnNCT02238522
What this trial is testing

Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML

Who this might be right for
Lymphoproliferative MalignanciesAcute Myeloid Leukemia
Zenith Epigenetics
Not applicableStudy completedNCT02640287
What this trial is testing

Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Central Hospital, Nancy, France 55
Post-approval studies (Phase 4)Looking for participantsNCT07169331
What this trial is testing

Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
BeiGene 18
Testing effectiveness (Phase 2)Study completedNCT01813227
What this trial is testing

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

Who this might be right for
Waldenstrom Macroglobulinemia
Hackensack Meridian Health 7
Load More Results